ICIs Exceptional Long Response in TNBC: Addressing the Issue of Optimal ICIs Duration. Two Cases and Review of the Literature

ABSTRACT Background Breast cancer is the leading cause of cancer‐related mortality in women, with triple‐negative breast cancer (TNBC) being an aggressive subtype associated with poor prognosis and limited treatment options. TNBC is known for its immunogenic characteristics, including high genetic i...

詳細記述

書誌詳細

主要な著者:	Simone Rota, Carolina Sciortino, Silvia Damian, Matteo Duca, Giorgia Villa, Matteo De Monte, Elisabella Ebrahem, Laura Cattaneo, Chiara Volpi, Alessandra Casale, Diletta Sorrentino, Sara Pessina, Antonia Martinetti, Filippo De Braud, Sara Cresta
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2025-11-01
シリーズ:	Cancer Reports
主題:	breast cancer immune checkpoint inhibitors immunotherapy systemic anticancer treatment triple negative breast cancer
オンライン･アクセス:	https://doi.org/10.1002/cnr2.70397
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!